Califf, who has close ties to the drug industry, said on a telephone conference call with reporters that one of his biggest priorities will be to figure out ways to streamline the clinical trial process.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.